ArticleThe oncologist2022

Joint-Predominant Rheumatic Complications of Immune Checkpoint Inhibitor Therapy in Patients with Thymic Epithelial Tumors.

Cristina Mullenix et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.